71 related articles for article (PubMed ID: 224075)
21. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
22. Unaltered stimulation of pituitary adrenocorticotrophin secretion by corticotrophin-releasing factor following sodium valproate administration in a patient with Nelson's syndrome.
Gomi M; Iida S; Itoh Y; Moriwaki K; Kanayama S; Namba M; Tarui S
Clin Endocrinol (Oxf); 1985 Aug; 23(2):123-7. PubMed ID: 2996808
[TBL] [Abstract][Full Text] [Related]
23. Cyproheptadine treatment of Nelson's syndrome: restoration of plasma ACTH circadian periodicity and reversal of response to TRF.
Krieger DT; Condon EM
J Clin Endocrinol Metab; 1978 Feb; 46(2):349-52. PubMed ID: 220278
[TBL] [Abstract][Full Text] [Related]
24. The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome.
Lamberts SW; Klijn JG; de Quijada M; Timmermans HA; Uitterlinden P; de Jong FH; Birkenhäger JC
J Clin Endocrinol Metab; 1980 Aug; 51(2):307-11. PubMed ID: 6249835
[No Abstract] [Full Text] [Related]
25. Plasma beta-endorphin responses to somatostatin, thyrotropin-releasing hormone, or vasopressin in Nelson's syndrome.
Oki S; Nakai Y; Nakao K; Imura H
J Clin Endocrinol Metab; 1980 Jan; 50(1):194-7. PubMed ID: 6243130
[TBL] [Abstract][Full Text] [Related]
26. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
[TBL] [Abstract][Full Text] [Related]
27. Effect of changes in the plasma ACTH level on the prolactin response to metoclopramide or bromocriptine in normal subjects and patients with Nelson's syndrome.
Nishida S; Matsuki M; Nagase Y; Horino M; Endoh M; Kakita K; Tenku A; Oyama H
Horm Metab Res; 1984 Feb; 16(2):107-8. PubMed ID: 6323292
[No Abstract] [Full Text] [Related]
28. [Is it possible to predict the development of Nelson's syndrome in Cushing's disease after bilateral adrenalectomy?].
Horký K; Kanka J; Gregorová I; Tomsová Z; Dvoráková J
Cas Lek Cesk; 1990 May; 129(21):645-9. PubMed ID: 2164450
[TBL] [Abstract][Full Text] [Related]
29. Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
Casulari LA; Naves LA; Mello PA; Pereira Neto A; Papadia C
Horm Res; 2004; 62(6):300-5. PubMed ID: 15557761
[TBL] [Abstract][Full Text] [Related]
30. [beta-endorphin secretion and its clinical significance in a patient with Nelson's syndrome (author's transl)].
Oki S; Nakao K; Nakai Y; Imura H
Nihon Naika Gakkai Zasshi; 1982 Apr; 71(4):458-66. PubMed ID: 6286812
[No Abstract] [Full Text] [Related]
31. Patient's age is a simple predictive factor for the development of Nelson's syndrome after total adrenalectomy for Cushing's disease.
Kemink L; Pieters G; Hermus A; Smals A; Kloppenborg P
J Clin Endocrinol Metab; 1994 Sep; 79(3):887-9. PubMed ID: 8077377
[TBL] [Abstract][Full Text] [Related]
32. Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome.
Assié G; Bahurel H; Coste J; Silvera S; Kujas M; Dugué MA; Karray F; Dousset B; Bertherat J; Legmann P; Bertagna X
J Clin Endocrinol Metab; 2007 Jan; 92(1):172-9. PubMed ID: 17062771
[TBL] [Abstract][Full Text] [Related]
33. The effect of magnesium valproate on plasma ACTH concentrations in Nelson's syndrome.
Kasperlik-Załuska A; Migdalska B; Jeske W; Drac-Kaniewska J; Wiśniewska-Woźniak T
Acta Med Pol; 1989; 30(1-2):9-15. PubMed ID: 2562233
[TBL] [Abstract][Full Text] [Related]
34. Nelson's syndrome and behavioural changes reversed by selective adenomectomy.
Buckler HM; Freeman H; Chetty MC; Anderson DC
Br J Psychiatry; 1988 Mar; 152():412-4. PubMed ID: 2844352
[TBL] [Abstract][Full Text] [Related]
35. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
[TBL] [Abstract][Full Text] [Related]
36. Characterization of lipotropin-, corticotropin-, and beta-endorphin-immunoreactive materials secreted in vitro by a human pituitary adenoma responsible for a case of Nelson's syndrome.
Bertagna X; Luton JP; Binoux M; Bricaire H; Girard F
J Clin Endocrinol Metab; 1979 Oct; 49(4):527-32. PubMed ID: 225344
[TBL] [Abstract][Full Text] [Related]
37. Multiple forms of bioactive and immunoreactive adrenocorticotropin in human pituitary and blood of patients with Nelson's syndrome.
Goverde HJ; Martens GJ; Pesman GJ; Smals AG
J Clin Endocrinol Metab; 1993 Aug; 77(2):443-7. PubMed ID: 8393886
[TBL] [Abstract][Full Text] [Related]
38. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV
Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740
[TBL] [Abstract][Full Text] [Related]
39. Secondary pituitary hyperplasia in Addison's disease.
Clayton R; Burden AC; Schrieber V; Rosenthal FD
Lancet; 1977 Nov; 2(8045):954-6. PubMed ID: 72291
[TBL] [Abstract][Full Text] [Related]
40. [Nelson's syndrome concomitant with Cushing's syndrome].
Vicente Delgado A; Lucas Morante T; Páramo Fernández C; Estrada García J; Marazuela Aspiroz M; de la Cuerda Compés C
Rev Clin Esp; 1991 Jun; 189(2):73-5. PubMed ID: 1784781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
